Autonomix Medical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Autonomix Medical, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 97% of Healthcare companies in United States.
- Shareholder Slice Ratio: Share count rose 981% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 90% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-632.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 97% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Autonomix Medical, Inc. made a loss over the last year. Autonomix Medical, Inc. owes $0.21 for every $1 it owns. Autonomix Medical, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Mar 2026.
P/E ratio
LossAutonomix Medical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.55The share price is 1.55 times Autonomix Medical, Inc.'s book value per share, lower than 66% of Healthcare companies in United States.
Market cap
$5 MThe total market value of all of Autonomix Medical, Inc.'s shares at today's price (share price × number of shares), smaller than 93% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$3 MWhat Autonomix Medical, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$1.61Net worth divided by the number of shares. The share price of $2.50 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
-316.0%Autonomix Medical, Inc. lost 316.0% of its shareholders' money over the last year, lower than 89% of Healthcare companies in United States.
Owes vs Owns
0.21×Autonomix Medical, Inc. owes $0.21 for every $1 it owns (low), lower than 71% of Healthcare companies in United States.
Dividend yield
NoneAutonomix Medical, Inc. does not currently pay a dividend.
Profit growth
LossAutonomix Medical, Inc. made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Autonomix Medical, Inc.: $5 M ÷ $3 M (30 Jun 2026) = 1.5.
What is Autonomix Medical, Inc.'s return on equity?
Autonomix Medical, Inc. lost 316.0% of its shareholders' money over the last year, lower than 89% of Healthcare companies in United States.
How much does Autonomix Medical, Inc. owe compared with what it owns?
Autonomix Medical, Inc. owes $0.21 for every $1 it owns (low), lower than 71% of Healthcare companies in United States.
Does Autonomix Medical, Inc. pay a dividend?
No. Autonomix Medical, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.